• Christopher White, an attorney with more than 15 years' experience in healthcare law, has been named general counsel of the Advanced Medical Technology Association (AdvaMed; Washington). Since 2001, White has been a partner in the FDA/Healthcare Regulation Practice of Morgan, Lewis, & Bockius, an international law firm that concentrates on the legal representation of the life sciences industry. As general counsel, White will serve as AdvaMed's chief legal officer, providing counsel on commercial contracts, corporate transactions and regulatory matters. He will also work with the association's legal committee to develop and promote positions on issues impacting patient access to medical technology. "Chris has a breadth of knowledge of the legal issues affecting the medical technology industry that is second to none," said AdvaMed President Stephen Ubl. "His extensive experience in the areas of business, finance, regulation and legislation, among others, will be an invaluable asset to AdvaMed as we promote the industry's agenda on issues such as protection of intellectual property and legal liability reform, as well as our continued efforts to communicate the importance of our Code of Ethics."

• Gregory Hare has joined Guardian Technologies International (Herndon, Virginia) as CFO. He replaces Bill Donovan, who recently was appointed Guardian's president and chief operating officer. From May 2001 until last month, Hare served as a financial executive of Jane Cosmetics. Guardian Technologies uses high-performance imaging technologies and advanced analytics to create integrated information management products and services.

• Matthew Posard has been named vice president of marketing with Illumina (San Diego). Most recently, he spent more than six years in various sales and marketing director positions at Biosite. Illumina develops next-generation tools for the large-scale analysis of genetic variation and function.

• Yvonne Briggs was appointed to the newly created position of vice president of business development for IRIS International (Chatsworth, California), a manufacturer of automated IVD urinalysis systems and medical devices. Prior to her appointment to IRIS, she was a vice president of investment banking at Oppenheimer & Co., focusing on emerging growth and middle-market companies in the healthcare sector.

• Robert Moss has been named national vice president of sales for Partners Imaging (Dallas). He joins the company from his previous position as regional vice president at Siemens Medical Systems. Partners Imaging provides computed tomography solutions for cardiovascular imaging.

• Robert Friel has been named president of Perkin-Elmer's (Boston) Life & Analytical Sciences unit, which focuses on providing applications-based solutions to customers in the genetic screening, biopharma and analytical sciences markets. Friel will succeed Peter Coggins, who will retire in February but will continue to serve as a senior advisor and consultant through mid-2007. Friel will continue as vice chairman of PerkinElmer, and remains a member of its board of directors. Prior to being appointed vice chairman, Friel served as executive vice president and CFO of the company, which he joined in 1999. Prior to that, he held several senior management positions at AlliedSignal, now Honeywell International. PerkinElmer also named Dr. Aaron Geist vice president, business development. He will be responsible for developing strategic partnerships and acquisition opportunities. Geist joins PerkinElmer from Robert W. Baird, where he served as director and senior research analyst. In that role, he was responsible for generating investor research on 22 life sciences, medical diagnostics and medical device companies.

• Prototype (Windsor, Connecticut), a laboratory automation provider, named Fran Tuttle president and CEO and as a member of the board of directors. Tuttle has more than 25 years of experience in life sciences leadership, most recently as senior vice president of near-patient testing at Bayer Diagnostics. The company also elected Rolf Classon chairman of the board. Prototype's BioCube System brings advanced industrial automation capabilities into life science and diagnostic laboratories.

• Third Wave Technologies (Madison, Wisconsin) reported changes to the company's management team associated with the succession last month of Kevin Conroy to president and CEO. Maneesh Arora, senior vice president of commercial operations, will begin transitioning to the position of CFO, to be completed by mid-March. James Herrmann will remain with the company as its principal financial officer through the filing of its annual report to effect a smooth transition. Gregory Hamilton, who has served as the company's executive director of planning and administration, has been appointed vice president of finance. John Bellano has been appointed vice president of sales. He succeeds Jake Orville, who will transition to a new role in the company. Bellano joined Third Wave as regional vice president of sales a year ago, coming from Roche Diagnostics. Third Wave develops molecular diagnostics for a variety of DNA and RNA analysis applications.